8-[5-((R)-3-Dimethylamino-pyrrolidine-1-sulfonyl)-2-propoxy-phenyl]-5-(4-fluoro-benzylamino)-2-(4-methoxy-benzyl)-2,7-dihydro-2,3,4,7,9-pentaaza-cyclopenta[a]naphthalen-6-one

ID: ALA81285

Chembl Id: CHEMBL81285

PubChem CID: 136032221

Max Phase: Preclinical

Molecular Formula: C38H41FN8O5S

Molecular Weight: 740.86

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCOc1ccc(S(=O)(=O)N2CC[C@@H](N(C)C)C2)cc1-c1nc(O)c2c(NCc3ccc(F)cc3)nc3nn(Cc4ccc(OC)cc4)cc3c2n1

Standard InChI:  InChI=1S/C38H41FN8O5S/c1-5-18-52-32-15-14-29(53(49,50)47-17-16-27(22-47)45(2)3)19-30(32)35-41-34-31-23-46(21-25-8-12-28(51-4)13-9-25)44-36(31)42-37(33(34)38(48)43-35)40-20-24-6-10-26(39)11-7-24/h6-15,19,23,27H,5,16-18,20-22H2,1-4H3,(H,40,42,44)(H,41,43,48)/t27-/m1/s1

Standard InChI Key:  BHJQVZCBKBFYOE-HHHXNRCGSA-N

Alternative Forms

  1. Parent:

    ALA81285

    ---

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 3 and 5 (PDE3 and PDE5) (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 740.86Molecular Weight (Monoisotopic): 740.2905AlogP: 5.67#Rotatable Bonds: 13
Polar Surface Area: 147.83Molecular Species: NEUTRALHBA: 12HBD: 2
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.05CX Basic pKa: 7.87CX LogP: 6.35CX LogD: 5.76
Aromatic Rings: 6Heavy Atoms: 53QED Weighted: 0.15Np Likeness Score: -1.56

References

1. Bi Y, Stoy P, Adam L, He B, Krupinski J, Normandin D, Pongrac R, Seliger L, Watson A, Macor JE..  (2001)  The discovery of novel, potent and selective PDE5 inhibitors.,  11  (18): [PMID:11549447] [10.1016/s0960-894x(01)00466-8]

Source